Cargando…
Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease
AIM: To evaluate the utility of fecal calprotectin (FC) in predicting relapse and endoscopic activity during follow-up in an inflammatory bowel disease (IBD) cohort. METHODS: All FC measurements that were obtained during a 3-year period from patients with inflammatory bowel disease in clinical remis...
Autores principales: | Kostas, Athanasios, Siakavellas, Spyros I, Kosmidis, Charalambos, Takou, Anna, Nikou, Joanna, Maropoulos, Georgios, Vlachogiannakos, John, Papatheodoridis, George V, Papaconstantinou, Ioannis, Bamias, Giorgos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685844/ https://www.ncbi.nlm.nih.gov/pubmed/29151692 http://dx.doi.org/10.3748/wjg.v23.i41.7387 |
Ejemplares similares
-
Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease
por: Rubio, Marrieth G, et al.
Publicado: (2019) -
Systematic Review with Network Meta-Analysis: Efficacy of Induction Therapy with a Second Biological Agent in Anti-TNF-Experienced Crohn's Disease Patients
por: Pagnini, Cristiano, et al.
Publicado: (2018) -
Colon mucosal neoplasia referred for endoscopic mucosal resection: Recurrence of adenomas and prediction of submucosal invasion
por: Rashid, Mamoon Ur, et al.
Publicado: (2020) -
Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease
por: Bamias, Giorgos, et al.
Publicado: (2016) -
Five years of fecal microbiota transplantation - an update of the Israeli experience
por: Greenberg, Sharon A, et al.
Publicado: (2018)